Biotech · Private company · Los Angeles, CA, US
Spinogenix
Track this companyFree. Adds Spinogenix to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SPG302Phase 2 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- SPG601Phase 2 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- TazbentetolALS (Amyotrophic Lateral Sclerosis)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of SPG302 in Adults With SchizophreniaPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 1, 2024ClinicalTrials.gov NCT06442462 · fetched Nov 12, 2026
- Study of SPG601 in Adult Men With Fragile X SyndromePHASE2 · COMPLETED · started Jul 5, 2024ClinicalTrials.gov NCT06413537 · fetched Nov 12, 2026
- Intermediate-size Patient Population Expanded Access ProtocolAVAILABLEClinicalTrials.gov NCT07088159 · fetched Nov 12, 2026
NIH awards1
- Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's DiseaseFiscal year 2024 · $1.6MNIH RePORTER 5R44AG082648-02 · fetched Nov 12, 2026